Choose language

  • bg

  • cs

  • da

  • de

  • el

  • en

  • es

  • et

  • fr

  • hr

  • hu

  • it

  • lt

  • lv

  • nl

  • no

  • pl

  • pt

  • ro

  • ru

  • sk

  • sl

  • sv

  • tr

  • uk

  • Български

  • Čeština

  • Danske

  • Deutsch

  • ελληνική

  • English

  • Español

  • Eesti keel

  • Français

  • Hrvatski

  • Magyar

  • Italiano

  • Lietuvių

  • Latviešu

  • Nederlands

  • Norsk

  • Polski

  • Português

  • Română

  • Русский

  • Slovenský

  • Slovenski

  • Svenska

  • Türkçe

  • Українська

How do you prefer to top up your account?

* We don't charge any commission for making deposits into your account

  • Home
  • News
  • Important: Freedom Finance Will Not Trade Ant Group IPO due to High Risks

Important: Freedom Finance Will Not Trade Ant Group IPO due to High Risks

Many of our clients are looking forward to Ant Group's upcoming IPO. This demand is quite understandable, as the Chinese fintech giant expects to raise $34.50B, which makes it the world's largest IPO over the last 20 years. There's no wonder that Ant Group, which was founded by Jack Ma, a billionaire and a founder of Alibaba Group, is in the spotlight of analysts, media, and investors across the globe.

The current demand for Ant Group IPO is 284 times higher than the supply, as the Chinese banks and brokers are offering retail investors a leverage, which is as high as up to 1:33. This is a lot even for OTC markets, and unbelievable for any stock market out there. This hype is very much likely to be artificially driven.

This is why Freedom Finance's Investment Committee decided not to trade Ant Group IPO, as the risks are too high. However, on the very first trading day, you can buy Ant Group shares directly from the Hong Kong Stock Exchange; this can be done through our online store, mobile applications, or Freedom24 trading platform.

If you were expecting Ant Group's IPO, don't get discouraged, as you have dozens of opportunities to invest your funds profitably with less risk. Since 2012, we have been offering an opportunity to invest into IPO's and undervalued stocks with good potential. Just yesterday it was the last day to apply for trading Atea Pharmaceuticals IPO with a 36% yield potential. Our analysts are researching some more upcoming IPO's, and we'll notify you about them soon.

In the meantime, while you are waiting for new IPO's, you can create a diversified portfolio of liquid securities. Please bear in mind that IPO investments are one of the most profitable, but at the same time one of the most risky instruments. Having a diversified portfolio is both our management's recommendation and the regulators' requirement. If you do not know how to build a portfolio, you can use our analysts' recommendations for USD or EUR portfolio.